Seqirus Email Format

Seqirus uses the first.last format, so Jane Smith would be jane.smith@seqirus.com.

Seqirus makes FLUAD Trivalent for adults 65 and older, an adjuvanted inactivated influenza vaccine that uses the MF59 adjuvant to boost immune response. A 2026 published U.S. study found FLUAD comparable in effectiveness to high-dose influenza vaccines in that age group.

Seqirus operates manufacturing facilities on three continents, including its Holly Springs, NC site in the U.S. and the Tullamarine cell culture facility near Melbourne, Australia, which commenced commercial operations in 2026 and supports both seasonal and pandemic vaccine supply.

Seqirus has a dedicated global cross-functional team for influenza pandemic preparedness and response, partnering with governments and public health agencies. In 2026, Canada signed a new pandemic preparedness contract with Seqirus to integrate its cell-based vaccine technology into national response plans.

Yes, Clay can help you identify and verify Seqirus contacts by role, region, or business function, making it straightforward to build a targeted list of the right people at Seqirus for partnership, sales, or public health outreach.